Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1

全外显子组测序揭示了两名NF1患者从原发性到转移性恶性周围神经鞘瘤的多克隆性特征。

阅读:2
作者:Abigail Godec ,Reyka Jayasinghe ,John S A Chrisinger ,Bethany Prudner ,Tyler Ball ,Yuxi Wang ,Divya Srihari ,Madhurima Kaushal ,Hilary Dietz ,Xiaochun Zhang ,Melike Pekmezci ,Sonika Dahiya ,Yu Tao ,Jinqin Luo ,Brian A Van Tine ,Li Ding ,David H Gutmann ,Angela C Hirbe

Abstract

Background: Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft tissue sarcomas with high metastatic rates and poor overall patient survival. There are currently no effective therapies, underscoring the pressing need to define the molecular etiologies that underlie MPNST progression. The aim of this study was to examine clonal progression and identify the molecular events critical for MPNST spread. Methods: In two patients with temporally and spatially distinct metastatic lesions, we employed whole exome sequencing (WES) to elucidate the genetic events of clonal progression, thus identifying the molecular events critical for MPNST spread. Results: First, we demonstrated shared clonal origins for the metastatic lesions relative to the primary tumors, which were maintained throughout the course of MPNST progression, supporting the conclusion that cancer cells with metastatic potential already exist in the primary neoplasm. Second, we discovered TRIM23, a member of the Tripartite Motif family of proteins, as a regulator of MPNST lung metastatic spread in vivo. Conclusions: The ability to track the genomic evolution from primary to metastatic MPNST offers new insights into the sequence of genetic events required for tumor progression and has identified TRIM23 as a novel target for future study in this rare cancer. Keywords: Genomics; MPNST; Metastasis; NF1; TRIM23.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。